The company is the first listed company under the Tong Ren Tang Group. The company was founded in 1997 and listed on the Shanghai Stock Exchange. After more than 20 years of development, the scale of the company has gradually expanded. The company's main business is the production and sale of proprietary Chinese medicines, and has a complete industrial chain including cultivation of Chinese herbal medicines, processing of Chinese herbal medicines, research and development of proprietary Chinese medicines, production of proprietary Chinese medicines, distribution of pharmaceuticals, wholesale and retail of pharmaceuticals. The main products include Liuwei Dihuang Pills, Jinqu Kidney Qi Pills, Beef Huang Detox Tablets, Cold Relief Granules, Ejiao, and Xihuang Pills. Corporate honors: In 2018, Tongrentang Group was awarded the “Top Ten Traditional Chinese Medicine National Brand Enterprises” by Beijing Tongrentang (Group) Co., Ltd., in 2018, Tongrentang Group won the “Most Promising Pharmaceutical Business Excellence Award” in the “China Drug Distribution Warring States Top 10” selection organized by the Health Science Bureau, and in 2018, Tongrentang Group won the “2017 Beijing Pharmaceutical Industry Vocational Skills Competition” Special Contribution Award, etc.
No Data